Acyclovir
Who holds supplier records for Acyclovir? 21 organisations hold a current record for Acyclovir: an active US FDA Type II Drug Master File or a CEP. A further 12 organisations have only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (3), Italy (2), Spain (2) and 2 other countries (2); not recorded for 4.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Acyclovir: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/acyclovir
Reading the evidence
- 21 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 11 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (21)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Acyclovir. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Aurore Life SciencesIndiaCEP Company GMP cert on recordActive DMF 34516, 36328 · latest filing Sept 2021
- OLON SPAItalyCEP Company GMP cert on recordActive DMF 10685, 20445 · latest filing Apr 2007
- YUNG ZIP CHEMICAL IND CO LTDActive DMF 10830, 19948 · latest filing Nov 2006
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 25587 · latest filing Dec 2011
- Hubei Yitai Pharmaceutical Co., LtdChinaCEPActive DMF 24919 · latest filing Apr 2011
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 13277 · latest filing Oct 1998
- QUIMICA SINTETICA SASpainCEP Company GMP cert on recordActive DMF 8584 · latest filing May 1990
- RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAItalyCEP Company GMP cert on recordActive DMF 10044 · latest filing Jan 1993
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)SpainCEPActive DMF 11896 · latest filing Mar 1996
- Zhejiang Charioteer Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 20203 · latest filing Jan 2007
- Zhejiang Jiuzhou Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 24934 · latest filing May 2011
- ZHEJIANG ZHEBEI PHARMACEUTICAL CO LTDCEPActive DMF 36071 · latest filing Aug 2021
- Apex Healthcare LimitedIndiaActive DMF 42067 · latest filing Jul 2025
- ATUL BIOSCIENCE LTDIndiaActive DMF 41584 · latest filing Mar 2025
- EMNAR PHARMA PRIVATE LTDIndiaActive DMF 44332 · latest filing Jul 2026
- GLOBELA INDUSTRIES PRIVATE LTDActive DMF 44733 · latest filing Sept 2026
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 25389 · latest filing Sept 2011
- SIGNA SA DE CVActive DMF 22949 · latest filing Jul 2009
- Teva Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 16144 · latest filing Sept 2002
- EXCELLA GMBH AND CO KGGermanyCEP Company GMP cert on recordInactive DMF 10671 · latest filing Jan 1994
- IndiaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (13)
Certificates of Suitability on the EDQM register for Acyclovir, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 20 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2020-013 - Rev 04 Aciclovir, Micronised and non-micronised | Jun 2026 | — |
| ZHEJIANG JIUZHOU PHARMACEUTICAL CO. LTD. Taizhou | CN | CEP 1997-084 - Rev 13 Aciclovir | Jun 2026 | Inspected Nov 2025 Hungary |
| HUBEI YITAI PHARMACEUTICAL CO., LTD. Tianmen | CN | CEP 2019-238 - Rev 02 Aciclovir | Apr 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 1998-029 - Rev 11 Aciclovir | Sept 2025 | — |
| OLON S.P.A. Rodano | IT | CEP 2003-218 - Rev 07 Aciclovir | Jul 2025 | Inspected Mar 2025 Italy |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2012-090 - Rev 03 Aciclovir | Dec 2024 | — |
| ZHEJIANG ZHEBEI PHARMACEUTICAL CO., LTD Xinshi Town, Deqing | CN | CEP 2022-077 - Rev 00 Aciclovir | Feb 2024 | — |
| ZHEJIANG CHARIOTEER PHARMACEUTICAL CO., LTD Xianju | CN | CEP 2001-283 - Rev 06 Aciclovir | Nov 2023 | Inspected Sept 2024 Italy |
| MANGALAM DRUGS & ORGANICS LTD. Mumbai | IN | R0-CEP 2020-314 - Rev 00 Aciclovir | Jul 2022 | — |
| RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. Milano | IT | R1-CEP 2007-213 - Rev 01 Aciclovir, Process B | Mar 2018 | — |
| QUIMICA SINTETICA S.A. Alcala De Henares | ES | R1-CEP 1998-126 - Rev 03 Aciclovir | Apr 2017 | — |
| EXCELLA GMBH & CO. KG Feucht | DE | R1-CEP 1998-040 - Rev 06 Aciclovir | Dec 2016 | — |
| Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona | ES | R1-CEP 1998-148 - Rev 05 Aciclovir | Dec 2016 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (12)
Organisations whose Type II DMFs for Acyclovir are no longer active. These show a past filing, not current supply.
Show all 12 historical records
- PHARMACEUTICAL WORKS POLPHARMA SAInactive DMF 26787 · filed Jan 2013
- QIDONG DONGYUE PHARMACEUTICAL CO., LTD.China · Inactive DMF 26659 · filed Apr 2012
- LIVZON GROUP CHANGZHOU KONY PHARMACEUTICAL CO LTDInactive DMF 17581 · filed Aug 2004
- ASTRA IDL LTDInactive DMF 15099 · filed Oct 2000
- SAMCHULLY PHARMACEUTICAL CO LTDInactive DMF 14865 · filed Jun 2000
- TEVA GROUPInactive DMF 12209, 14654 · filed Dec 1999
- MALLINCKRODT CHEMICAL INCInactive DMF 11974, 12621 · filed Aug 1997
- India · Inactive DMF 12159 · filed Oct 1996
- ISTITUTO BIOLOGICO CHEMIOTERAPICO SPA DIVISIONE UNIBIOSInactive DMF 11981 · filed May 1996
- India · Inactive DMF 10710 · filed Feb 1994
- OMNICHEM SAInactive DMF 10124 · filed Mar 1993
- LACHEMA BRNOInactive DMF 9530 · filed Jan 1992
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Acyclovir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL184).
Chemical identity
- IUPAC name
- 2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one
- Canonical SMILES
- C1=NC2=C(N1COCCO)NC(=NC2=O)N
- InChIKey
- MKUXAQIIEYXACX-UHFFFAOYSA-N
- Synonyms
- Aciclovir, Aciclovirum, Acycloguanosine, Acyclovir, Acyclovir component of xerese, Avaclyr, Avert, Clearsore, Cymex ultra, Duvimex, Gerpevir, Herpetad
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
- Mechanism of action
- DNA Polymerase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Acyclovir?
21 organisations hold an active US FDA Type II Drug Master File or a CEP for Acyclovir: Aurore Life Sciences (India), OLON SPA (Italy), YUNG ZIP CHEMICAL IND CO LTD, Hetero Drugs Limited (India), Hubei Yitai Pharmaceutical Co., Ltd (China), MATRIX PHARMACORP PRIVATE LTD (India), QUIMICA SINTETICA SA (Spain) and RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (Italy), and 13 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Acyclovir Drug Master Files are active?
Aurore Life Sciences (DMF 34516, 36328), OLON SPA (DMF 10685, 20445), YUNG ZIP CHEMICAL IND CO LTD (DMF 10830, 19948), Hetero Drugs Limited (DMF 25587), Hubei Yitai Pharmaceutical Co., Ltd (DMF 24919), MATRIX PHARMACORP PRIVATE LTD (DMF 13277), QUIMICA SINTETICA SA (DMF 8584) and RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (DMF 10044) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Acyclovir records mean?
12 organisations have only inactive Type II DMFs for Acyclovir. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Acyclovir have a European Certificate of Suitability?
Yes. 13 organisations hold a valid CEP for Acyclovir on the EDQM register, including AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), ZHEJIANG JIUZHOU PHARMACEUTICAL CO. LTD. Taizhou (CN), HUBEI YITAI PHARMACEUTICAL CO., LTD. Tianmen (CN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), OLON S.P.A. Rodano (IT) and HETERO DRUGS LIMITED Hyderabad (IN) and 7 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Acyclovir supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Acyclovir?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.